The Company is engaged principally in the ownership, operation, management, selective redevelopment, development and acquisition of properties for the life sciences industry.
BATS data provided in real-time. NYSE, NASDAQ and AMEX data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates and Analyst Ratings provided by Zacks.
SEC Filings and Insider Transactions provided by Edgar Online.
Powered and implemented by Interactive Data Managed Solutions. Terms & Conditions
RSS Headlines
Fool UK
Recs
Well-run REIT with low leverage, but this quality and more are priced-in. Wtih top-end FFO guidance of $4.57 per share, the stock has an FFO yield of 5.86%. The dividend yield is currently 2.30%. Neither should inspire market beating returns given the current headwinds in commercial real estate.